| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Microbiology and Immunology, Allegheny University of the Health Sciences, Philadelphia, PA 19129
Immunization with DNA vaccines encoding relevant Ags can induce not only cell-mediated immune response but also humoral immune responses against pathogenic microorganisms in several animal models. Our previous results demonstrated that, when the C terminus (PyC2) of Plasmodium yoelii merozoite surface protein-1 (MSP-1), a leading vaccine candidate against erythrocytic stages of malaria, was expressed as a fusion protein (GST-PyC2) with glutathione S-transferase (GST), it elicited Ab-mediated protective immune responses in BALB/c mice. In our present study, we wished to examine the humoral responses to a DNA vaccine (V3) encoding GST-PyC2. The GST-PyC2 expressed in V3-transfected Cos 7 cells was recognized by a protective monoclonal Ab to PyC2 (mAb302), although the secreted product had undergone N-linked glycosylation. When BALB/c mice were immunized with V3 plasmid, anti-PyC2 Abs were successfully induced. These Abs immunoprecipitated native PyMSP-1 protein and competed with mAb302 for binding to its epitope at a level similar to those elicited by GST-PyC2 protein immunization. However, these Abs had significantly lower titers and avidities, and different isotype profiles and protective capacities against a lethal erythrocytic stage challenge, than those resulting from immunization with GST-PyC2 protein. Most surprising was the finding that, in contrast to protein immunization, there was no significant increase in the avidity of either GST-specific or PyC2-specific IgG Abs during the course of DNA immunization. This suggests that there may be little or no affinity maturation of specific Abs during DNA immunization in this system.
This article has been cited by other articles:
|
|
 |
|
  M. G. Chaitra, M. S. Shaila, and R. Nayak Evaluation of T-cell responses to peptides with MHC class I-binding motifs derived from PE_PGRS 33 protein of Mycobacterium tuberculosis J. Med. Microbiol., April 1, 2007; 56(4): 466 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kawabata, H. Udono, K. Honma, M. Ueda, H. Mukae, J.-i. Kadota, S. Kohno, and K. Yui Merozoite Surface Protein 1-Specific Immune Response Is Protective against Exoerythrocytic Forms of Plasmodium yoelii Infect. Immun., November 1, 2002; 70(11): 6075 - 6082. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Tanghe, S. D'Souza, V. Rosseels, O. Denis, T. H. M. Ottenhoff, W. Dalemans, C. Wheeler, and K. Huygen Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting Infect. Immun., May 1, 2001; 69(5): 3041 - 3047. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-P. Sauzet, B.-L. Perlaza, K. Brahimi, P. Daubersies, and P. Druilhe DNA Immunization by Plasmodium falciparum Liver-Stage Antigen 3 Induces Protection against Plasmodium yoelii Sporozoite Challenge Infect. Immun., February 1, 2001; 69(2): 1202 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Wunderlich, I. C. Moura, and H. A. del Portillo Genetic Immunization of BALB/c mice with a Plasmid Bearing the Gene Coding for a Hybrid Merozoite Surface Protein 1-Hepatitis B Virus Surface Protein Fusion Protects Mice against Lethal Plasmodium chabaudi chabaudi PC1 Infection Infect. Immun., October 1, 2000; 68(10): 5839 - 5845. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ahlborg, I. T. Ling, A. A. Holder, and E. M. Riley Linkage of Exogenous T-cell Epitopes to the 19-Kilodalton Region of Plasmodium yoelii Merozoite Surface Protein 1 (MSP119) Can Enhance Protective Immunity against Malaria and Modulate the Immunoglobulin Subclass Response to MSP119 Infect. Immun., April 1, 2000; 68(4): 2102 - 2109. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
